Publication: Implant exposure and extrusion
dc.contributor.author | Christina Garusi | en_US |
dc.contributor.author | Visnu Lohsiriwat | en_US |
dc.contributor.other | Istituto Europeo di Oncologia | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-10-19T05:37:48Z | |
dc.date.available | 2018-10-19T05:37:48Z | |
dc.date.issued | 2013-01-01 | en_US |
dc.description.abstract | © Springer-Verlag Italia 2013. The salvage of the infected and or exposed breast prosthesis remains a challenging but viable option for a subset of patients. Keys to success include culture-directed antibiotics, capsulectomy, device exchange, and adequate soft tissue coverage. Relative contraindications to breast device salvage include atypical pathogens on wound culture, such as Gram-negative rods, methicillin-resistant <Emphasis Type=–Italic—>Staphylococcus aureus</Emphasis>, and <Emphasis Type=–Italic—>Candida parapsilosis</Emphasis>. Patients with a prior device infection and exposure and a history of either radiotherapy or <Emphasis Type=–Italic—>S. aureus</Emphasis> on wound culture should be closely monitored for signs of recurrent breast prosthesis infection/exposure and managed cautiously in the setting of elective breast surgery. | en_US |
dc.identifier.citation | Oncoplastic and Reconstructive Breast Surgery. (2013), 315-320 | en_US |
dc.identifier.doi | 10.1007/978-88-470-2652-0_32 | en_US |
dc.identifier.other | 2-s2.0-84956726027 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/32649 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956726027&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Implant exposure and extrusion | en_US |
dc.type | Chapter | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956726027&origin=inward | en_US |